{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:47:19Z","timestamp":1764604039769,"version":"3.40.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:00:00Z","timestamp":1709596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.fjurol.2024.102606","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T16:10:50Z","timestamp":1711210250000},"page":"102606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary urethral carcinoma: Recommendations of the oncology committee of the French Urology Association"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0241-021X","authenticated-orcid":false,"given":"Paul","family":"Neuville","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Murez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre Henri","family":"Savoie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Fl\u00e9chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Van Hove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Branger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Camparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fjurol.2024.102606_bib0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.fjurol.2024.102606_bib0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humpath.2017.08.006","article-title":"Carcinoma of the urethra","volume":"72","author":"Zhang","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0305","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00345-015-1583-7","article-title":"Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma","volume":"34","author":"Gakis","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0310","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.humpath.2022.08.003","article-title":"Female urethral carcinoma: a contemporary review of the clinicopathologic features, with emphasis on the histoanatomic landmarks and potential staging issues","volume":"129","author":"Lagarde-Lenon","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0315","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/0377-4929.97895","article-title":"Clear cell adenocarcinoma of the male urethral tract","volume":"55","author":"Gandhi","year":"2012","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0320","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0090-4295(98)00199-X","article-title":"Management of primary urethral cancer","volume":"52","author":"Gheiler","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102606_bib0325","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.urology.2006.08.1057","article-title":"Incidence of primary urethral carcinoma in the United States","volume":"68","author":"Swartz","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102606_bib0330","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0090-4295(98)00659-1","article-title":"Male urethral carcinoma: analysis of treatment outcome","volume":"53","author":"Dalbagni","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102606_bib0335","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.urolonc.2012.01.011","article-title":"Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists","volume":"31","author":"Dayyani","year":"2013","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.urology.2003.08.007","article-title":"Role of voided urine cytology in diagnosing primary urethral carcinoma","volume":"63","author":"Touijer","year":"2004","journal-title":"Urology"},{"issue":"Suppl. 1","key":"10.1016\/j.fjurol.2024.102606_bib0345","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1148\/rg.24si045504","article-title":"Imaging of urethral disease: a pictorial review","volume":"24","author":"Kawashima","year":"2004","journal-title":"Radiographics"},{"key":"10.1016\/j.fjurol.2024.102606_bib0350","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ucl.2010.04.014","article-title":"Imaging tumors of the penis and urethra","volume":"37","author":"Stewart","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.fjurol.2024.102606_bib0355","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.crad.2011.07.039","article-title":"MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration","volume":"66","author":"Gourtsoyianni","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0360","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.rcl.2013.07.001","article-title":"Magnetic resonance imaging of female urethral and periurethral disorders","volume":"51","author":"Surabhi","year":"2013","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.fjurol.2024.102606_bib0365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00192-015-2790-x","article-title":"MRI of female urethra and periurethral pathologies","volume":"27","author":"Itani","year":"2016","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.fjurol.2024.102606_bib0370","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2214\/AJR.16.16929","article-title":"Clear cell adenocarcinoma of the urethra in women: distinctive MRI findings for differentiation from nonadenocarcinoma and non-clear cell adenocarcinoma of the urethra","volume":"208","author":"Kim","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0375","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3346\/jkms.2009.24.1.162","article-title":"Endometrioid adenocarcinoma in urethrovaginal septum: a diagnostic pitfall","volume":"24","author":"Lim","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.fjurol.2024.102606_bib0380","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/RCT.0b013e31816789f4","article-title":"Clear cell adenocarcinoma of the female urethra: magnetic resonance imaging","volume":"33","author":"Takeuchi","year":"2009","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.fjurol.2024.102606_bib0385","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/RLU.0000000000000548","article-title":"Clear cell adenocarcinoma of the urethra: 18F-FDG PET\/CT imaging","volume":"40","author":"Nguyen","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.fjurol.2024.102606_bib0390","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/annonc\/mdv230","article-title":"Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international colla*boration on primary urethral carcinoma","volume":"26","author":"Gakis","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0395","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.21.02051","article-title":"Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: results of the GETUG-AFU V05 VESPER Trial","volume":"40","author":"Pfister","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0400","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clgc.2022.01.011","article-title":"Association between perioperative chemotherapy and survival in men undergoing radical resection for primary urethral urothelial carcinoma: an analysis of the National Cancer Database","volume":"20","author":"Celtik","year":"2022","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.fjurol.2024.102606_bib0405","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.juro.2014.07.105","article-title":"Combined chemoradiation as primary treatment for invasive male urethral cancer","volume":"193","author":"Kent","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0410","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1464-410X.2007.06901.x","article-title":"Penile-preserving surgery for male distal urethral carcinoma","volume":"100","author":"Smith","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102606_bib0415","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s11255-014-0678-1","article-title":"Distal urethrectomy for localized penile squamous carcinoma in situ extending into the urethra: an updated series","volume":"46","author":"Pedrosa","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0420","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ucl.2016.06.011","article-title":"Management of proximal primary urethral cancer: should multidisciplinary therapy be the gold standard?","volume":"43","author":"Zinman","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.fjurol.2024.102606_bib0425","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1464-410X.2008.08210.x","article-title":"Prostatic urothelial carcinoma: is transurethral prostatectomy necessary before bacillus Calmette-Gu\u00e9rin immunotherapy?","volume":"103","author":"Gofrit","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102606_bib0430","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/bju.12486","article-title":"Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy","volume":"114","author":"Knoedler","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102606_bib0435","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10147-012-0508-3","article-title":"Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens","volume":"19","author":"Ichihara","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0440","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/cren.2015.0026","article-title":"Primary adenocarcinoma of the urethra: a case report and review of the literature","volume":"1","author":"Basiri","year":"2015","journal-title":"J Endourol Case Rep"},{"key":"10.1016\/j.fjurol.2024.102606_bib0445","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/PAS.0b013e31802ff7c4","article-title":"Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases","volume":"31","author":"Osunkoya","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0450","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jmrs.371","article-title":"A case study of the radiation therapy treatment of a transitional cell carcinoma of the distal urethra","volume":"67","author":"Donovan","year":"2020","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.fjurol.2024.102606_bib0455","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1464-410X.1998.00878.x","article-title":"Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy","volume":"82","author":"Dalbagni","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0460","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.euf.2019.07.001","article-title":"Current disease management of primary urethral carcinoma","volume":"5","author":"Janisch","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.fjurol.2024.102606_bib0465","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1078-1439(03)00174-1","article-title":"Surgical treatment for local control of female urethral carcinoma","volume":"22","author":"Dimarco","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0470","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.eururo.2013.03.044","article-title":"EAU guidelines on primary urethral carcinoma","volume":"64","author":"Gakis","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0475","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.AOG.0000124848.63750.e6","article-title":"Periurethral masses: etiology and diagnosis in a large series of women","volume":"103","author":"Blaivas","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0480","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11255-009-9618-x","article-title":"Urethral diverticular carcinoma: an overview of current trends in diagnosis and management","volume":"42","author":"Ahmed","year":"2010","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0485","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/1097-0142(19930515)71:10<3102::AID-CNCR2820711034>3.0.CO;2-2","article-title":"Primary carcinoma of the female urethra. Results of radiation therapy","volume":"71","author":"Garden","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.fjurol.2024.102606_bib0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-8140(00)00208-5","article-title":"Urethral carcinoma in women: results of treatment with primary radiotherapy","volume":"56","author":"Milosevic","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0495","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijrobp.2018.06.007","article-title":"Optimizing the role of surgery and radiation therapy in urethral cancer based on histology and disease extent","volume":"102","author":"Son","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.fjurol.2024.102606_bib0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.09.012","article-title":"The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma","volume":"36","author":"Gakis","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.07.026","article-title":"Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: a National Cancer Database Analysis","volume":"35","author":"Cahn","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0510","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.purol.2022.08.009","article-title":"French AFU Cancer Committee Guidelines\u00a0\u2013\u00a0Update 2022\u20132024: penile cancer","volume":"32","author":"Savoie","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2018.09.014","article-title":"The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma","volume":"36","author":"Werntz","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0520","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.euo.2020.06.003","article-title":"European Association of Urology Guidelines on Primary Urethral Carcinoma\u00a0\u2013\u00a02020 Update","volume":"3","author":"Gakis","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0525","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa2002788","article-title":"Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma","volume":"383","author":"Powles","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fjurol.2024.102606_bib0530","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.2147\/CMAR.S184197","article-title":"Prognosis of rare pathological primary urethral carcinoma","volume":"10","author":"Abudurexiti","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.fjurol.2024.102606_bib0535","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.urology.2016.09.042","article-title":"Outcomes and prognostic factors of primary urethral cancer","volume":"100","author":"Sui","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.fjurol.2024.102606_bib0540","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clgc.2020.12.001","article-title":"Sex-related differences include stage, histology, and survival in urethral cancer patients","volume":"19","author":"Wenzel","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.fjurol.2024.102606_bib0545","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1186\/s12885-021-08603-z","article-title":"Primary tumor surgery improves survival in non-metastatic primary urethral carcinoma patients: a large population-based investigation","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.fjurol.2024.102606_bib0550","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/cncr.25787","article-title":"Prognostic factors in male urethral cancer","volume":"117","author":"Rabbani","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.fjurol.2024.102606_bib0555","doi-asserted-by":"crossref","first-page":"e1131","DOI":"10.1016\/j.clgc.2017.07.006","article-title":"Diagnosing distal urethral carcinomas in men might be only the tip of the iceberg","volume":"15","author":"Torbrand","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.fjurol.2024.102606_bib0560","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1442-2042.2006.01392.x","article-title":"Clinical outcome of 36 male patients with primary urethral carcinoma: a single center experience","volume":"13","author":"Thyavihally","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0565","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000448335","article-title":"Oncological outcomes of patients with concomitant bladder and urethral carcinoma","volume":"97","author":"Gakis","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.fjurol.2024.102606_bib0570","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/bju.15095","article-title":"Primary urethral cancer: treatment patterns and associated outcomes","volume":"126","author":"Mano","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102606_bib0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.09.020","article-title":"The effect of centralization of care on overall survival in primary urethral cancer","volume":"39","author":"Stone","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.fjurol.2024.102606_bib0580","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11255-019-02314-y","article-title":"Nomograms for predicting long-term overall survival and cancer-specific survival in patients with primary urethral carcinoma: a population-based study","volume":"52","author":"Zi","year":"2020","journal-title":"Int Urol Nephrol"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024000639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024000639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T21:24:42Z","timestamp":1717449882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393024000639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2950393024000639"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102606","relation":{},"ISSN":["2950-3930"],"issn-type":[{"type":"print","value":"2950-3930"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary urethral carcinoma: Recommendations of the oncology committee of the French Urology Association","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102606"}}